Comments

NeuroPace Stock Price, Quotes and Forecasts

Q: What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NPCENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

NeuroPace (NPCE) Forecast

News Earnings NeuroPace (NPCE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

NeuroPace Stock Price, Quotes and Forecasts | NASDAQ:NPCE | Benzinga

Explore NeuroPace stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NPCE.

Open	$13.11
Close	-
Volume / Avg.	53.02K / 287.85K
Day Range	$12.48 - $13.20
52 Wk Range	5.45 - 18.98
Market Cap	$429.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	2.07%
Days to Cover	1.44

Recent News

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA pathway discussions.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$13.11
Close	-
Volume / Avg.	53.02K / 287.85K
Day Range	$12.48 - $13.20
52 Wk Range	5.45 - 18.98
Market Cap	$429.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	2.07%
Days to Cover	1.44

About NeuroPace Inc

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of peop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroPace (NPCE) stock?

You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.

View our list of the best stock brokerages

Who are NeuroPace (NPCE) competitors?

Other companies in NeuroPace’s space includes: CeriBell (NASDAQ:CBLL), Axogen (NASDAQ:AXGN), Kestra Medical Techs (NASDAQ:KMTS), SI-BONE (NASDAQ:SIBN) and Semler Scientific (NASDAQ:SMLR).

What is the forecast, or price target, for NeuroPace (NPCE) stock?

NeuroPace has a consensus price target of $16.00.

What is the current price for NeuroPace (NPCE)?

The stock price for NeuroPace (NASDAQ: NPCE) is $13.1 last updated June 3, 2025 at 11:40 AM EDT.

Does NeuroPace (NPCE) pay a dividend?

There are no upcoming dividends for NeuroPace.

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

NeuroPace’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is NeuroPace (NPCE) going to split?

There is no upcoming split for NeuroPace.

What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.